West Nile Virus fears prompt US blood recall
This article was originally published in Clinica
Blood centres in the US are voluntarily withdrawing some frozen blood products in the wake of reports that 13 persons acquired the West Nile virus this year from eight infected donors. The blood products being pulled from the market were donated during the time of year when mosquitoes were transmitting the virus to humans.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.